Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Regulatory News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price: 6.10
Bid: 6.00
Ask: 6.20
Change: -0.25 (-3.94%)
Spread: 0.20 (3.33%)
Open: 6.35
High: 6.35
Low: 6.10
Yest. Close: 6.35
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
12
Date   Source Headline
26th Sep 20197:00 amRNSPosters at Cancer Immunotherapy Conference
12th Sep 20193:56 pmRNSScancell Hlds - Result of AGM
4th Sep 20197:00 amRNSScancell Hlds - First Collaboration Agreement for AvidiMab
20th Aug 20192:23 pmRNSScancell Hlds - Notice of AGM
20th Aug 20197:00 amRNSScancell Hlds - Final Results for the year ended 30 April 2019
19th Aug 20197:00 amRNSScancell Hlds - Update on the SCIB1 Phase 2 clinical trial
7th Aug 20197:00 amRNSScancell Hlds - Notice of Final Results
1st Jul 20197:00 amRNSScancell Hlds - H1 2019 Business Update
18th Jun 20199:16 amRNSScancell Hlds - Holding(s) in Company
18th Jun 20197:00 amRNSScancell Hlds - Board Appointment
17th Jun 201910:45 amRNSScancell Hlds - Holding(s) in Company
14th Jun 20194:41 pmRNSScancell Hlds - Second Price Monitoring Extn
14th Jun 20194:35 pmRNSScancell Hlds - Price Monitoring Extension
13th Jun 20197:00 amRNSScancell Hlds - Share Subscription and Issue of Equity to Vulpes
29th May 201911:05 amRNSScancell Hlds - Second Price Monitoring Extn
29th May 201911:00 amRNSScancell Hlds - Price Monitoring Extension
20th May 20197:00 amRNSScancell Hlds - Scancell and CRUK provide an update on SCIB2
10th May 20197:00 amRNSScancell Hlds - Clinical Advisory Board and Update on Modi-1
25th Apr 20197:00 amRNSScancell Hlds - UK approval to start SCIB1 Phase 2 trial
8th Apr 20197:00 amRNSScancell Hlds - Japan patent for Moditope immunotherapy platform
21st Mar 20197:00 amRNSScancell Hlds - Professor Lindy Durrant receives Waldenström award
20th Mar 20197:00 amRNSScancell Hlds - Scancell strengthens IP portfolio
5th Mar 20196:27 pmRNSScancell Hlds - Holding(s) in Company
4th Mar 20194:40 pmRNSScancell Hlds - Second Price Monitoring Extn
4th Mar 20194:35 pmRNSScancell Hlds - Price Monitoring Extension
21st Feb 20197:00 amRNSScancell Hlds - Change of Auditor
31st Jan 20197:00 amRNSScancell Hlds - Interim Results
23rd Jan 20197:00 amRNSScancell Hlds - Update on Cancer Research UK's Grand Challenge
21st Jan 20197:00 amRNSScancell Hlds - Appoints Heads of Research and Manufacturing
30th Oct 20185:18 pmRNSScancell Hlds - Results of AGM
30th Oct 20187:00 amRNSScancell Hlds - Identification of 2nd Moditope Cancer Vaccine
24th Oct 20189:05 amRNSScancell Hlds - Second Price Monitoring Extn
24th Oct 20189:00 amRNSScancell Hlds - Price Monitoring Extension
24th Oct 20187:00 amRNSScancell Hlds - Update on SCIB1 Phase 2 Clinical Study
25th Sep 20187:00 amRNSScancell Hlds - Final Results for the year ended 30 April 2018
18th Sep 20187:00 amRNSScancell Hlds - Notice of Final Results
9th Aug 20187:00 amRNSScancell Hlds - Agreement
25th Jul 20182:45 pmRNSScancell Hlds - Director/PDMR Shareholding
24th Jul 20187:00 amRNSScancell Hlds - Issue of Equity
11th May 20181:11 pmRNSScancell Hlds - Holding(s) in Company
9th May 201810:12 amRNSScancell Hlds - Holding(s) in Company
8th May 20187:00 amRNSScancell Hlds - Result of the Open Offer and PDMR Shareholdings
23rd Apr 201812:43 pmRNSScancell Hlds - Holding(s) in Company
20th Apr 20184:32 pmRNSScancell Hlds - Holding(s) in Company
18th Apr 20182:29 pmRNSScancell Hlds - Result of Placing and Subscription and PDMR
18th Apr 201811:05 amRNSScancell Hlds - Second Price Monitoring Extn
18th Apr 201811:00 amRNSScancell Hlds - Price Monitoring Extension
18th Apr 20187:00 amRNSScancell Hlds - Technology acquired from University of Nottingham
16th Feb 201811:30 amRNSScancell to present at the Calculus Investor Forum
15th Feb 20187:15 amRNSHardman Res. - Validating multiple opportunities
12

Login to your account

Don't have an account? Click here to register.